Skip to the page

Data / Form D filings / Intelligent Therapeutics, Inc.

Intelligent Therapeutics, Inc.: Form D filing

Intelligent Therapeutics, Inc., a technology company in Eugene, OR, filed a Form D with the SEC in 2026. The latest, on May 28, 2026, reports $100,000 sold of a $700,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
220 EAST 11TH AVENUE SUITE 6, Eugene, OR, 97401
Phone
(541) 232-5062
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2136711

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 28, 2026New notice$700,000$100,000$600,0002May 13, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jason GallicExecutive Officer, DirectorPresident and Chief Executive Officer
Nathan BernsteinExecutive Officer, DirectorChief Technology Officer
Thomas EmmonsExecutive Officer, DirectorChief Financial Officer, Secretary
Michael ZvolenskyExecutive Officer, DirectorChief Science Officer
David ShearDirector

Other technology companies in Oregon that filed recently

Every Form D from the week of May 25, 2026 · All recent filings in Oregon · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Intelligent Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.